Jane Street Group, LLC Atossa Therapeutics, Inc. Call Options Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$1.11 - $1.74 $862,470 - $1.35 Million	-777,000 Reduced 91.11%	75,800 $95,000
Q4 2021 Feb 15, 2022	SELL	$1.6 - $3.27 $1.18 Million - $2.41 Million	-737,600 Reduced 46.38%	852,800 $1.36 Million
Q3 2021 Nov 16, 2021	SELL	$2.89 - $6.4 $4.1 Million - $9.09 Million	-1,419,800 Reduced 47.17%	1,590,400 $5.19 Million
Q2 2021 Aug 16, 2021	BUY	$1.52 - $8.62 $3.71 Million - $21 Million	2,441,100 Added 428.94%	3,010,200 $19 Million
Q1 2021 May 18, 2021	BUY	$0.92 - $4.33 $523,572 - $2.46 Million	569,100 New	569,100 $1.2 Million

26.5M

466K

91.8K

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $130M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.